Summit Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy

74

SMMT
Summit Therapeutics

Last Price:

24.34

Seasonality Move:

26.72%

Sell

19

APLS
Apellis Pharmaceuticals

Last Price:

32.49

Seasonality Move:

18.8%

Buy

74

Summit Therapeutics (SMMT) is a Buy

Is Summit Therapeutics a Buy, Sell or Hold?

The current Summit Therapeutics [SMMT] share price is $24.39. The Score for SMMT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

19

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

The Summit Therapeutics share price today is $24.39
The current trend is moderately bullish and SMMT is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.83	Buy
Relative Strength Index (14 RSI):	62.93	Buy
Chaikin Money Flow:	4296288	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.22 - 24.22)	Buy
Bollinger Bands (100):	(4.41 - 16.03)	Buy

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.84	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	-1084788	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(36.37 - 40.01)	Sell
Bollinger Bands (100):	(36.55 - 42.35)	Sell

SMMT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	26.23	Sell
20-day SMA:	19	Buy
50-day SMA:	13.97	Buy
200-day SMA:	6.94	Buy
8-day EMA:	24.24	Buy
20-day EMA:	20.51	Buy
50-day EMA:	15.51	Buy
200-day EMA:	8.51	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.19	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	50	Sell
8-day EMA:	35.96	Sell
20-day EMA:	37.21	Sell
50-day EMA:	38.25	Sell
200-day EMA:	45.7	Sell

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Summit Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):